References
- Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M., Tommasini R. Pharmacological study on a new oral anti-diabetic: N-{ 4[R-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexyl-urea or K4024. Arzneim.-forsch 1971; 21: 2081. Ambrogi V., Bloch K., Daturi S., Griggi P., Logemann W., Mandelli V., Parenti M. A., Rabini T., Usardi M., Tommasini R. Pharmacological study on a new oral anti-diabetic: N-{ 4[R-(5-methyl-pyrazine-2-carboxamido)-ethyl]-benzene-sulphonyl }-N'-cyclohexyl-urea or K4024. Arzneim.-forsch 1971; 21: 208
- Fuccella L. M., Tamassia V., Valzelli G. Metabolism and kinetics of the hypo-glycemic agent glipizide in man - comparison with glibenclamide. J. clin. Pharmacol 1973; 13: 652. Fuccella L. M., Tamassia V., Valzelli G. Metabolism and kinetics of the hypo-glycemic agent glipizide in man - comparison with glibenclamide. J. clin. Pharmacol 1973; 13: 65
- Marigo S., Del Nevo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim.-forsch 1971; 21: 2153. Marigo S., Del Nevo G., Bini P. P., Sacchetti G. Pharmacological methods for evaluating a new hypoglycaemic agent in humans: a multistep design. Arzneim.-forsch 1971; 21: 215